metformin and salinomycin

metformin has been researched along with salinomycin in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	4 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Economopoulou, P; Kaklamani, VG; Siziopikou, K	1
Knyazev, P; Sperl, B; Ullrich, A; Xiao, Z	1
Huczyński, A; Markowska, A; Markowska, J; Sajdak, S	1
Huczyński, A; Markowska, A; Markowska, J; Rehlis, S; Sajdak, S	1

Reviews

3 review(s) available for metformin and salinomycin

Article	Year
The role of cancer stem cells in breast cancer initiation and progression: potential cancer stem cell-directed therapies. The oncologist, 2012, Volume: 17, Issue:11 Topics: Aldehyde Dehydrogenase 1 Family; Breast Neoplasms; CD24 Antigen; Cell Differentiation; Cell Transformation, Neoplastic; Disease Progression; Drug Resistance, Neoplasm; Female; Humans; Hyaluronan Receptors; Isoenzymes; Metformin; Neoplasm Invasiveness; Neoplastic Stem Cells; Pyrans; Retinal Dehydrogenase; Treatment Outcome	2012
Angiogenesis and cancer stem cells: New perspectives on therapy of ovarian cancer. European journal of medicinal chemistry, 2017, Dec-15, Volume: 142 Topics: Angiogenesis Inhibitors; Animals; Anti-Bacterial Agents; Bevacizumab; Female; Humans; Hypoglycemic Agents; Metformin; Neoplastic Stem Cells; Neovascularization, Pathologic; Ovarian Neoplasms; Ovary; Pyrans	2017
Ovarian cancer stem cells: A target for oncological therapy. Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 2018, Volume: 27, Issue:7 Topics: Animals; Cell Proliferation; Enterotoxins; Female; Humans; Metformin; Neoplastic Stem Cells; Ovarian Neoplasms; Pyrans	2018

Other Studies

1 other study(ies) available for metformin and salinomycin

Article	Year
Metformin and salinomycin as the best combination for the eradication of NSCLC monolayer cells and their alveospheres (cancer stem cells) irrespective of EGFR, KRAS, EML4/ALK and LKB1 status. Oncotarget, 2014, Dec-30, Volume: 5, Issue:24 Topics: AMP-Activated Protein Kinase Kinases; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Cycle Proteins; Cell Line, Tumor; ErbB Receptors; Humans; Lung Neoplasms; Metformin; Microtubule-Associated Proteins; Neoplastic Stem Cells; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); Pyrans; ras Proteins; Serine Endopeptidases; Signal Transduction	2014

Article

Year

Metformin and salinomycin as the best combination for the eradication of NSCLC monolayer cells and their alveospheres (cancer stem cells) irrespective of EGFR, KRAS, EML4/ALK and LKB1 status.

Oncotarget, 2014, Dec-30, Volume: 5, Issue:24

Topics: AMP-Activated Protein Kinase Kinases; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Cycle Proteins; Cell Line, Tumor; ErbB Receptors; Humans; Lung Neoplasms; Metformin; Microtubule-Associated Proteins; Neoplastic Stem Cells; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); Pyrans; ras Proteins; Serine Endopeptidases; Signal Transduction

2014